Mauro Boiago
Overview
Explore the profile of Mauro Boiago including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buono A, Zito A, Kim W, Fabris T, De Biase C, Bellamoli M, et al.
JACC Cardiovasc Interv
. 2024 Nov;
PMID: 39570223
Background: Balloon-expandable valves (BEVs) and self-expanding valves (SEVs) have different features that may impact the outcomes of patients with Sievers type 1 bicuspid aortic valve (BAV) stenosis undergoing transcatheter aortic...
2.
Cesario V, Oliva O, De Biase C, Beneduce A, Boiago M, Dumonteil N, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458073
Over the past few years, transcatheter aortic valve implantation (TAVI) imposed itself as the first-choice therapy for symptomatic aortic stenosis (AS) in elderly patients at surgical risk. There have been...
3.
Buono A, De Biase C, Fabris T, Bellamoli M, Kim W, Montarello N, et al.
Int J Cardiol
. 2024 Sep;
417():132569.
PMID: 39303924
Background: Raphe-type bicuspid aortic valve (BAV) is a potential hostile scenario in trans-catheter aortic valve replacement (TAVR) due to pronounced calcium burden, possibly associated with tapered valve configuration. Trans-Catheter heart...
4.
Beneduce A, Oliva O, Cesario V, Boiago M, De Biase C, Tchetche D, et al.
JACC Cardiovasc Interv
. 2024 May;
17(14):1743-1745.
PMID: 38749450
No abstract available.
5.
Zito A, Buono A, Scotti A, Kim W, Fabris T, De Biase C, et al.
JACC Cardiovasc Interv
. 2024 May;
17(14):1652-1663.
PMID: 38749449
Background: Transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BAV) stenosis is technically challenging and is burdened by an increased risk of paravalvular regurgitation (PVR). Objectives: The...
6.
Boiago M, Bellamoli M, De Biase C, Beneduce A, Gutierrez Alonso L, Laforgia P, et al.
Catheter Cardiovasc Interv
. 2024 Apr;
103(6):1004-1014.
PMID: 38577939
Introduction: Bicuspid aortic valve (BAV) stenosis is a complex anatomical scenario for transcatheter aortic valve implantation (TAVI). Favorable short-term clinical outcomes have been reported with TAVI in this setting, but...
7.
Hagemeyer D, Merdad A, Villegas Sierra L, Ruberti A, Kargoli F, Bouchat M, et al.
JACC Cardiovasc Interv
. 2024 Feb;
17(4):552-560.
PMID: 38418058
Background: Transcatheter tricuspid valve replacement (TTVR) abolishes tricuspid regurgitation (TR) and has emerged as a definitive treatment for TR. Objectives: The purpose of this multicenter, observational study was to determine...
8.
Gutierrez L, Boiago M, De Biase C, Oliva O, Laforgia P, Feliachi S, et al.
J Clin Med
. 2023 Nov;
12(22).
PMID: 38002687
Bicuspid aortic valve (BAV) is the most common congenital heart disease, with a prevalence of 1-2% and occurring in >20% of octogenarians referred for aortic valve replacement. However, BAV patients...
9.
Tchetche D, Boiago M
JACC Cardiovasc Interv
. 2022 Aug;
15(16):1661-1663.
PMID: 35981840
No abstract available.
10.
Scotti A, Fovino L, Coisne A, Fabris T, Cardaioli F, Massussi M, et al.
Front Cardiovasc Med
. 2022 Jun;
9:924958.
PMID: 35757343
Background: The impact of transcatheter aortic valve replacement (TAVR) leaflet design on long-term device performance is still unknown. This study sought to compare the clinical and hemodynamic outcomes of intra-...